WinstonWınston
Noble Roman's logo

Noble Roman's

NROM
53
Restaurants · Consumer Cyclical
Price
$0.64
+0.00 (+0.00%)
Market Cap
$14.2M
Winston Score
53
Winston is curious
Mixed quality — meaningful strengths and weaknesses.

Share count rising — dilution

+35.7% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 23.6M (2021) → 32.1M (2025)

Noble Roman's is a small American pizza company based in Indianapolis, Indiana. It sells pizza, breadsticks, and other Italian-style food under the Noble Roman's brand. Instead of running its own restaurants, it mainly licenses its brand and recipes to other businesses — like gas stations, grocery stores, and entertainment venues — that sell Noble Roman's food as an add-on to their existing operations.

The company makes money primarily through franchise royalties and licensing fees, meaning it collects a cut of sales from its partners without owning the physical locations. It operates almost entirely in the United States and has a very small market cap, making it a micro-cap stock. Its asset-light model keeps costs low, which helps explain its solid operating margin for such a tiny company. The main risk is its heavy dependence on a limited number of licensing partners and its small scale, which leaves little room for error if key relationships end or consumer demand for its products softens.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+6.8% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+231.0% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (4%)

Research and development spending

Insider Activity

19.8%ownership

Declining

Insider ownership declining — could be dilution or selling

Cash Position

Cash flow positive

$719,500 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Noble Roman's is growing revenue at 7% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
31.1%
Modest — 31.1% gross margin
Operating Margin
19.8%
Healthy — 19.8% operating margin
ROCE
6.6%
Weak — 6.6% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+6.1%
Slow sales growth (6.1% YoY)
EPS YoY
+206.6%
Earnings growing fast (206.6% YoY)

Earnings growing 25%+ a year. The compounder zone.

EPS Consistency
6/8 quarters
Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
135%
Turns 135% of profit into real cash
FCF Margin
7.5%
Modest free cash flow (7.5%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
2.67
Heavy debt load (2.67)
Interest Cover
1.48x
Dangerous — barely covers interest (1.5x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
15.2x
Fair value — P/E 15.2

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial